WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 48.88
-0.74 (-1.49%)
Nov 11, 2026, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 200.59 billion as of November 10, 2026. It is the 994th most valuable company in the world and the 47th biggest in Hong Kong. Its market cap has increased by 43.96% in one year.
Market Cap
200.59B
Enterprise Value
196.14B
Revenue
27.27B
Global Rank
Country Rank
#47 Hong Kong
PE Ratio
35.75
ChartMarket Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 200.59B, an increase of 526.09%. That is a compound annual growth rate of 21.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 200.59B | 54.35% |
| Dec 31, 2025 | 129.96B | 80.25% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 364.46B |
| Innovent Biologics | 150.33B |
| Sichuan Kelun-Biotech Biopharmaceutical | 108.71B |
| Sino Biopharmaceutical | 99.74B |
| Akeso | 80.23B |
| Genscript Biotech | 69.28B |
| RemeGen | 54.09B |
| 3SBio | 37.83B |